The use of aliskiren as an antifibrotic drug in experimental models: A systematic review
Sign Up to like & getrecommendations! Published in 2019 at "Drug Development Research"
DOI: 10.1002/ddr.21610
Abstract: Aliskiren is an oral antihypertensive medication that acts by directly inhibiting renin. High levels of circulating renin and prorenin activate the pathological signaling pathway of fibrosis. This drug also reduces oxidative stress. Thus, the aim… read more here.
Keywords: experimental models; fibrosis; systematic review; drug ... See more keywords